Diorganotin (IV) derivative of 2-thiophene acetic acid: characterizations and biological activities of {[n-Bu2SnO2C–CH2–C4H3S]2O}2
New organotin (IV) derivatives of thiophene acetic acid have been prepared and characterized by IR, 1 H- and 13 C-NMR spectroscopic techniques. A single crystal of {[ n -Bu 2 SnO 2 C–CH 2 –C 4 H 3 S] 2 O} 2 has been synthesized and its cell parameters were measured. It crystallizes in the monoclinic...
Gespeichert in:
Veröffentlicht in: | Medicinal chemistry research 2012-11, Vol.21 (11), p.3607-3614 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | New organotin (IV) derivatives of thiophene acetic acid have been prepared and characterized by IR,
1
H- and
13
C-NMR spectroscopic techniques. A single crystal of {[
n
-Bu
2
SnO
2
C–CH
2
–C
4
H
3
S]
2
O}
2
has been synthesized and its cell parameters were measured. It crystallizes in the monoclinic system (
P
2
1
) [
a
= 15.1337(7),
b
= 12.2587(5),
c
= 18.8766(9), and β = 105.811(5)°]. The compound showed selective inhibitory effect against β-glucuronidase enzyme (IC
50
3.1 ± 0.1 μM), which is more potent than our standard,
d
-saccharic acid 1,4-lactone (IC
50
48.4 ± 1.3 μM). Also, it exhibited immunomodulatory activity, and cytotoxicity against PC-3 cell line (IC
50
= 16.9 ± 1.3 μM, and 1.2 ± 0.1 μM, respectively), which are close to the standards ibuprofen (IC
50
11.8 ± 1.8 μM), and doxorubicin (IC
50
0.9 ± 0.1 μM), respectively. This compound did not show any significant inhibition for other biological test such as α-chymotrypsin, urease, phosphodiesterase enzymes, and antiglycation activity. |
---|---|
ISSN: | 1054-2523 1554-8120 |
DOI: | 10.1007/s00044-011-9916-6 |